Mirabegron Treatment for Chronic Pulmonary Hypertension Associated With Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial
Eur. J. Heart Fail 2022 Nov 20;[EPub Ahead of Print], A García-Álvarez, I Blanco, I García-Lunar, P Jordà, JJ Rodriguez-Arias, L Fernández-Friera, I Zegri, J Nuche, M Gomez-Bueno, S Prat, S Pujadas, E Sole-Gonzalez, MD Garcia-Cossio, M Rivas, E Torrecilla, D Pereda, J Sanchez, P García-Pavía, J Segovia-Cubero, JF Delgado, S Mirabet, V Fuster, JA Barberá, B IbañezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.